Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents

Citation
Da. Jobe et al., Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents, CL DIAG LAB, 6(6), 1999, pp. 930-933
Citations number
32
Categorie Soggetti
Immunology
Journal title
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
ISSN journal
1071412X → ACNP
Volume
6
Issue
6
Year of publication
1999
Pages
930 - 933
Database
ISI
SICI code
1071-412X(199911)6:6<930:DOBAIL>2.0.ZU;2-F
Abstract
The borreliacidal-antibody test has been used for the serological detection and confirmation of Lyme borreliosis. However, the presence of antimicrobi al agents in serum can confound the accurate detection of borreliacidal ant ibodies. In this study, we developed a Bacillus subtilis agar diffusion bio assay to detect small concentrations of antimicrobial agents in serum. We a lso used XAD-16, a nonionic polymeric resin, to adsorb and remove high conc entrations of amoxicillin, cefotaxime, ceftriaxone, cefuroxime, doxycycline , and erythromycin without significantly affecting even small concentration s of immunoglobulin M (IgM) or IgG borreliacidal antibodies. High concentra tions of penicillin could also be removed by adding 1 U of penicillinase wi thout significantly influencing the levels of borreliacidal antibodies. The se simple procedures greatly enhance the clinical utility of the borreliaci dal-antibody test.